National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

betulinic acid
A pentacyclic lupane-type triterpene derivative of betulin (isolated from the bark of Betula alba, the common white birch) with antiinflammatory, anti-HIV and antineoplastic activities. Betulinic acid induces apoptosis through induction of changes in mitochondrial membrane potential, production of reactive oxygen species, and opening of mitochondrial permeability transition pores, resulting in the release of mitochondrial apogenic factors, activation of caspases, and DNA fragmentation. Although originally thought to exhibit specific cytotoxicity against melanoma cells, this agent has been found to be cytotoxic against non-melanoma tumor cell types including neuroectodermal.and brain tumor cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Mairin
Acronym:BA
Code name:ALS-357
Chemical structure name:(3beta)-3-Hydroxy-lup-20(29)-en-28-oic Acid



Previous:beta-thioguanine deoxyriboside, Betadine, BetaMarc, betamethasone, Betaseron
Next:bevacizumab, bexarotene, Bextra, Bexxar, BI 2536

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov